Press Releases


2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000-1996


December 26, 2012
BD Completes Acquisition of Safety Syringes, Inc.

December 21, 2012
BD to Present at Investor Healthcare Conferences

December 10, 2012
Medication Errors from Injectable Drugs Harm One Million Inpatients Each Year Adding Billions in Cost, New Study Finds

November 20, 2012
BD Board Increases Dividend by 10 Percent

November 07, 2012
BD Announces Results for 2012 Fourth Fiscal Quarter and Full Year

November 06, 2012
BD Announces Funding and Product Support for Hurricane Sandy Relief Efforts

November 06, 2012
BD Announces Appointment of William A. Kozy as Chief Operating Officer

November 01, 2012
BD Completes Sale of Majority of Discovery Labware Unit

October 31, 2012
First Partner Assay on the BD MAX™ System Launches in Europe

October 29, 2012
BD is Awarded WindMade™ Certification; Ranks Among Top 40 U.S. Companies in Newsweek's 2012 Green Rankings

October 17, 2012
New Molecular Test Available to Diagnose Trichomonas vaginalis in Asymptomatic and Symptomatic Females

October 12, 2012
BD and Lab21 Collaborate to Develop New Oncology Assays on the BD MAX™ Platform

October 11, 2012
New Disposable Pen Injector Offers Ease of Use as well as Customization Options for Use with a Wide Range of Injectable Drugs

October 10, 2012
BD Announces Chief Financial Officer Transition

October 02, 2012
New RSV Test Provides Reliable Results in Minutes

October 02, 2012
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call

September 28, 2012
Leading Microbiology Expert Joins BD Diagnostics in Maryland

September 26, 2012
New Molecular Assay Detects Rapidly Emerging Multidrug-Resistant Superbug

September 20, 2012
New Influenza Test Offers Labs Advanced Performance and Reliable Results

September 19, 2012
BD Introduces Advanced Needle Technology Designed to Enhance Patient Comfort and Improve Patient Adherence in Diabetes Care

September 04, 2012
New Initiative to Advance Health Workers' Blood Collection Skills

August 27, 2012
BD Acquires Sirigen Group Limited

August 14, 2012
New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug

August 02, 2012
BD Announces Results for 2012 Third Fiscal Quarter

July 26, 2012
BD and PEPFAR Launch Labs for Life to Strengthen Laboratories in Regions Heavily Burdened by Disease

July 25, 2012
BD Launches New Needle Designed to Improve Performance and Patient Comfort

July 24, 2012
BD Board Declares Dividend

July 23, 2012
BD Board of Directors Elects Rebecca W. Rimel

July 16, 2012
New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining High-Quality Standards

July 11, 2012
BD Announces Agreement to Acquire Safety Syringes, Inc.

July 09, 2012
New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug

June 28, 2012
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

June 20, 2012
New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of Life Science Applications

June 07, 2012
JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes

May 30, 2012
BD to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference

May 23, 2012
BD Issues 2011 Sustainability Report

May 22, 2012
BD Board Declares Dividend

May 22, 2012
BD Appoints CEO Vincent A. Forlenza as Chairman of the Board

May 21, 2012
BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti

May 02, 2012
BD Opens Major Distribution Center in Four Oaks, North Carolina

May 02, 2012
BD to Present at Investor Healthcare Conferences

May 01, 2012
BD Announces Results for 2012 Second Fiscal Quarter

April 10, 2012
BD Signs Agreement to Sell Majority of Discovery Labware Unit
Advanced Bioprocessing Platform Excluded from Sale


April 02, 2012
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

March 29, 2012
New Assay Rapidly Identifies Lethal Pathogen Responsible for Clostridium difficile Infection

March 27, 2012
New IVD Product is Designed to Improve Prevention and Control of GBS in Newborns

March 26, 2012
New Collaboration Aims to Improve Access to TB Diagnostics

March 09, 2012
BD to Present at the Barclays Capital Global Healthcare Conference

March 07, 2012
Study Shows Nurses are Exposed To Risks from Blood Exposure During Insertion and Removal of Peripheral IV Catheter

March 01, 2012
Nationwide Educational Tour Kicks Off on the Future of Molecular Diagnostics

February 13, 2012
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies to Offer Integrated Microbiology Lab Solutions

February 13, 2012
BD Acquires KIESTRA Lab Automation BV

February 13, 2012
First Specimen Collection Training Curriculum in Sub-Saharan Africa Launches at Kenyan Medical Training College

February 10, 2012
BD to Present at Investor Healthcare Conferences

February 07, 2012
Mesenchymal Stem Cells Have New Cell Culture Environment

February 06, 2012
BD Announces Results for 2012 First Fiscal Quarter

January 31, 2012
BD Board Declares Dividend

January 24, 2012
BD Announces Webcast of Annual Meeting of Shareholders

January 18, 2012
BD and Mercy/ROi Collaborate to Improve Quality of Care and Reduce Costs

January 11, 2012
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

January 04, 2012
BD to Present at the 30th Annual J. P. Morgan Healthcare Conference

Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2014 BD